Search All News
Opening remarks were delivered by Dr. Blair Simpson, interim chair of psychiatry at Columbia.
A Columbia study, which enrolls children ages 4-6 in a camp-like setting, seeks to learn which play activities best soothe anxious children.
Data from Columbia Mass Murder Database reveal psychosis and other serious psychiatric illness absent in the majority of perpetrators.
An NIH award will help fund a collaborative effort of Columbia University's Department of Pediatrics and Department of Psychiatry titled Prospective Genetic Risk Evaluation and Assessment in Autism.
- May 15, 2019
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM) is the largest study ever done on late-life depression. OPTIMUM’s New York site is located at NYSPI/Columbia.
- April 15, 2019
Columbia Psychiatrists suggest that researchers, pharmaceutical companies, and the FDA reconsider placebo-controlled, relapse prevention studies in schizophrenia.
Source:JAMAApril 10, 2019
Dr. Jeffrey Lieberman and colleagues conclude that the time has come to cease the use of placebo in relapse prevention studies and encourage the use of active comparators.
- March 21, 2019
A new study from Columbia University and New York State Psychiatric Institute offers insight into the development of delusions, which could lead to better treatments for people with psychosis.
Source:MD ALERTFebruary 28, 2019
"I expect that clinicians will change their practices by prescribing fewer benzodiazepines and more antidepressants for people with schizophrenia," Dr. T. Scott Stroup said.
Source:HealioFebruary 21, 2019
“The effectiveness of combinations of antipsychotic medications remains unclear; reviews of this treatment strategy agree on the need for further investigation,” Dr. T. Scott Stroup and team wrote.
- February 20, 2019
Patients with schizophrenia are often treated with more than one type of psychiatric medication, but a new study suggests that some combinations may be more effective than others.
- February 19, 2019
Researchers have developed a practical and accurate self-report screener for detecting early psychosis and enabling early treatment.